Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Golgi SNAP receptor complex member 2 (GOSR2) is a trafficking membrane protein that serves as a Qb-SNARE, facilitating the transport of proteins from the endoplasmic reticulum (ER) and ER-Golgi intermediate compartment (ERGIC) to the medial and trans-Golgi network[3][4][5]. It is an integral part of the SNARE complex, interacting with other SNAREs—such as syntaxin-5, Bet1, and Sec22b—to mediate vesicle docking and fusion events that are essential for intracellular protein trafficking[5]. Mutations in the GOSR2 gene disrupt these trafficking processes and cause a spectrum of neurologic diseases, most notably North Sea progressive myoclonus epilepsy (NS-PME) and congenital muscular dystrophy, typically resulting in epilepsy, myoclonus, muscle weakness, and motor development delays, but generally with preserved cognition[1][2][5]. There are three main transcript variants of GOSR2, and disease mutations tend to affect highly conserved sites within its SNARE motif critical for complex formation and function[2][5][3]. No direct interacting drugs or established biomarker or screening paradigms are reported for GOSR2 as of current knowledge.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Golgi SNAP receptor complex member 2 (GOSR2).